Down to $6.5m market cap , One can only keep accumulating in this environment.
Intrepid - Phase II trial for TBI (fully funded)
http://www.neurenpharma.com/ssl/CMS/files_cms/Arrowhead%20TBI%20Conference%20NNZ2566%20Presentation.pdf
Motiva - Phase II trial for Post Stroke Apathy (fully funded)
http://www.asx.net.au/asxpdf/20100303/pdf/31p1qnxh4rctvw.pdf
Perseis - Currently selecting antibodies from preclinical trials (seeking collaboration to accelerate development)
http://www.neurenpharma.com/ssl/CMS/files_cms/Perseis%20Overview%20Mar11.pdf
- Forums
- ASX - By Stock
- NEU
- neu comparison vs other biotechs
neu comparison vs other biotechs, page-2
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEU (ASX) to my watchlist
(20min delay)
|
|||||
Last
$13.61 |
Change
-0.590(4.15%) |
Mkt cap ! $1.739B |
Open | High | Low | Value | Volume |
$13.88 | $13.91 | $13.29 | $13.29M | 982.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 20000 | $13.60 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$13.63 | 1000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1500 | 13.550 |
2 | 4497 | 13.530 |
1 | 3378 | 13.520 |
15 | 29080 | 13.500 |
1 | 3079 | 13.470 |
Price($) | Vol. | No. |
---|---|---|
13.630 | 1000 | 1 |
13.680 | 3079 | 1 |
13.700 | 1000 | 1 |
13.710 | 3079 | 1 |
13.740 | 3079 | 1 |
Last trade - 16.10pm 08/10/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
AHK
ARK MINES LIMITED
Ben Emery, Executive Director
Ben Emery
Executive Director
SPONSORED BY The Market Online